|
1
|
Perez RP: Cellular and molecular
determinants of cisplatin resistance. Eur J Cancer. 34:1535–1542.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tiseo M, Franciosi V, Grossi F and
Ardizzoni A: Adjuvant chemotherapy for non-small cell lung cancer:
ready for clinical practice? Eur J Cancer. 42:8–16. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Katoh R, Takebayashi Y and Takenoshita S:
Expression of copper-transporting P-type adenosine triphosphatase
(ATP7B) as a chemoresistance marker in human solid carcinomas. Ann
Thorac Cardiovasc Surg. 11:143–145. 2005.PubMed/NCBI
|
|
4
|
Safaei R: Role of copper transporters in
the uptake and efflux of platinum containing drugs. Cancer Lett.
234:34–39. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tanzi RE, Petrukhin K, Chernov I, et al:
The Wilson disease gene is a copper transporting ATPase with
homology to the Menkes disease gene. Nat Genet. 5:344–350. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Safaei R, Holzer AK, Katano K, Samimi G
and Howell SB: The role of copper transporters in the development
of resistance to Pt drugs. J Inorg Biochem. 98:1607–1613. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Komatsu M, Sumizawa T, Mutoh M, Chen ZS,
Terada K, Furukawa T, Yang XL, Gao H, Miura N, Sugiyama T and
Akiyama S: Copper-transporting P-type adenosine triphosphatase
(ATP7B) is associated with cisplatin resistance. Cancer Res.
60:1312–1316. 2000.PubMed/NCBI
|
|
8
|
Katano K, Safaei R, Samimi G, Holzer A,
Tomioka M, Goodman M and Howell SB: Confocal microscopic analysis
of the interaction between cisplatin and the copper transporter
ATP7B in human ovarian carcinoma cells. Clin Cancer Res.
10:4578–4588. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nakayama K, Kanzaki A, Ogawa K, Miyazaki
K, Neamati N and Takebayashi Y: Copper-transporting P-type
adenosine triphosphatase (ATP7B) as a cisplatin based
chemoresistance marker in ovarian carcinoma: comparative analysis
with expression of MDR1, MRP1, MRP2, LRP and BCRP. Int J Cancer.
101:488–495. 2002. View Article : Google Scholar
|
|
10
|
Kobayashi H: Collagen gel droplet culture
method to examine in vitro chemosensitivity. Methods Mol Med.
110:59–67. 2005.PubMed/NCBI
|
|
11
|
Kobayashi H: Development of a new in vitro
chemosensitivity test using collagen gel droplet embedded culture
and image analysis for clinical usefulness. Recent Results Cancer
Res. 161:48–61. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Inoue Y, Gika M, Abiko T, Oyama T, Saitoh
Y, Yamazaki H, Nakamura M, Abe Y, Kawamura M and Kobayashi K: Bcl-2
overexpression enhances in vitro sensitivity against
docetaxel in non-small cell lung cancer. Oncol Rep. 13:259–264.
2005.PubMed/NCBI
|
|
13
|
Kawamura M, Gika M, Abiko T, Inoue Y,
Oyama T, Izumi Y, Kobayashi H and Kobayashi K: Clinical evaluation
of chemosensitivity testing for patients with unresectable
non-small cell lung cancer (NSCLC) using collagen gel droplet
embedded culture drug sensitivity test (CD-DST). Cancer Chemother
Pharmacol. 59:507–513. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nakagawa T, Inoue Y, Kodama H, Yamazaki H,
Kawai K, Suemizu H, Masuda R, Iwazaki M, Yamada S, Ueyama Y, Inoue
H and Nakamura M: Expression of copper-transporting P-type
adenosine triphosphatase (ATP7B) correlates with cisplatin
resistance in human non-small cell lung cancer xenografts. Oncol
Rep. 20:265–270. 2008.PubMed/NCBI
|
|
15
|
Nishi M, Abe Y, Fujimori S, Hamamoto A,
Inoue Y, Miyazaki N, Oida Y, Ikoma N, Ohnishi Y, Yamazaki H, Ueyama
Y and Nakamura M: The modifier subunit of glutamate cysteine ligase
relates to cisplatin resistance in human small-cell lung cancer
xenografts in vivo. Oncol Rep. 14:421–424. 2005.PubMed/NCBI
|
|
16
|
Fujimori S, Abe Y, Nishi M, Hamamoto A,
Inoue Y, Ohnishi Y, Nishime C, Matsumoto H, Yamazaki H, Kijima H,
Ueyama Y, Inoue H and Nakamura M: The subunits of glutamate
cysteine ligase enhance cisplatin resistance in human non-small
cell lung cancer xenografts in vivo. Int J Oncol.
25:413–418. 2004.PubMed/NCBI
|
|
17
|
Terada K, Schilsky ML, Miura N and
Sugiyama T: ATP7B (WND) protein. Int J Biochem Cell Biol.
30:1063–1067. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Harris ED, Qian Y, Tiffany-Castiglioni E,
Lacy AR and Reddy MC: Functional analysis of copper homeostasis in
cell culture models: a new perspective on internal copper
transport. Am J Clin Nutr. 67:988–995. 1998.PubMed/NCBI
|
|
19
|
Higashimoto M, Kanzaki A, Shimakawa T,
Konno S, Naritaka Y, Nitta Y, Mori S, Shirata S, Yoshida A, Terada
K, Sugiyama T, Ogawa K and Takebayashi Y: Expression of
copper-transporting P-type adenosine triphosphatase in human
esophageal carcinoma. Int J Mol Med. 11:337–341. 2003.PubMed/NCBI
|
|
20
|
Petrukhin K, Lutsenko S, Chernov I, Ross
BM, Kaplan JH and Gilliam TC: Characterization of the Wilson
disease gene encoding a P-type copper transporting ATPase: genomic
organization, alternative splicing, and structure/function
predictions. Hum Mol Genet. 3:1647–1656. 1994. View Article : Google Scholar
|
|
21
|
Nakayama K, Miyazaki K, Kanzaki A,
Fukumoto M and Takebayashi Y: Expression and cisplatin sensitivity
of copper-transporting P-type adenosine triphosphatase (ATP7B) in
human solid carcinoma cell lines. Oncol Rep. 8:1285–1287.
2001.PubMed/NCBI
|
|
22
|
Katano K, Safaei R, Samimi G, Holzer A,
Rochdi M and Howell SB: The copper export pump ATP7B modulates the
cellular pharmacology of carboplatin in ovarian carcinoma cells.
Mol Pharmacol. 64:466–473. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Nakayama K, Kanzaki A, Terada K, Mutoh M,
Ogawa K, Sugiyama T, Takenoshita S, Itoh K, Yaegashi N, Miyazaki K,
Neamati N and Takebayashi Y: Prognostic value of the
Cu-transporting ATPase in ovarian carcinoma patients receiving
cisplatin-based chemotherapy. Clin Cancer Res. 10:2804–2811. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Miyashita H, Nitta Y, Mori S, Kanzaki A,
Nakayama K, Terada K, Sugiyama T, Kawamura H, Sato A, Morikawa H,
Motegi K and Takebayashi Y: Expression of copper-transporting
P-type adenosine triphosphatase (ATP7B) as a chemoresistance marker
in human oral squamous cell carcinoma treated with cisplatin. Oral
Oncol. 39:157–162. 2003. View Article : Google Scholar : PubMed/NCBI
|
